External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

Diabetologia

Volumn 54, Issue 2, 2011, Pages 264-270

  Van Dieren, S ^a   Peelen, L M ^a   Nothlings U ^b,c   Van Der Schouw, Y T ^a   Rutten, G E H M ^a   Spijkerman, A M W ^d   Van Der A, D L ^d   Sluik, D ^b   Boeing, H ^b   Moons, K G M ^a   Beulens, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Calibration; Cardiovascular disease; Coronary heart disease; Discrimination; Epidemiology; Multiple imputation; Prediction; Type 2 diabetes mellitus; Validation

Indexed keywords

ADULT; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISCRIMINANT ANALYSIS; EXTERNAL VALIDITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; UK PROSPECTIVE DIABETES STUDY; VALIDATION STUDY;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 78951474314     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1960-0     Document Type: Article

References (26)

1. P Koskinen M Manttari V Manninen JK Huttunen OP Heinonen MH Frick 1992 Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study Diabetes Care 15 820 825 1:STN:280:DyaK38zoslSltA%3D%3D 10.2337/diacare.15.7.820 1516498
2. RM Conroy K Pyörälä AP Fitzgerald, et al. 2003 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987 1003 1:STN:280:DC%2BD3s3mtFGnuw%3D%3D 10.1016/S0195-668X(03) 00114-3 12788299
3. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS (2009) Predicting the 30-year risk of cardiovascular disease. The Framingham Heart Study. Circulation
4. RK Simmons RL Coleman HC Price, et al. 2009 Performance of the UK prospective diabetes study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort Diabetes Care 32 708 713 10.2337/dc08-1918 19114615
5. RN Guzder W Gatling MA Mullee RL Mehta CD Byrne 2005 Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom study Diabet Med 22 554 562 1:STN:280:DC%2BD2M3gvVOhtA%3D%3D 10.1111/j.1464-5491.2005.01494.x 15842509
6. JW Stephens G Ambler P Vallance DJ Betteridge SE Humphries SJ Hurel 2004 Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil 11 521 528 10.1097/00149831- 200412000-00013 15580065
7. X Yang WY So AP Kong, et al. 2008 Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus Am J Cardiol 101 596 601 10.1016/j.amjcard.2007.10.019 18308005
8. RJ Stevens V Kothari AI Adler IM Stratton 2001 The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56) Clin Sci (Lond) 101 671 679 1:STN:280:DC%2BD3MnnvVOrtQ%3D%3D 10.1042/CS20000335
9. J Cederholm K Eeg-Olofsson B Eliasson B Zethelius PM Nilsson S Gudbjornsdottir 2008 Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register Diabetes Care 31 2038 2043 10.2337/dc08-0662 18591403
10. P Chamnan RK Simmons SJ Sharp SJ Griffin NJ Wareham 2009 Cardiovascular risk assessment scores for people with diabetes: a systematic review Diabetologia 52 2001 2014 1:STN:280:DC%2BD1Mngt1ehsg%3D%3D 10.1007/s00125-009- 1454-0 19629430
11. AA van der Heijden MM Ortegon LW Niessen G Nijpels JM Dekker 2009 Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study Diabetes Care 32 2094 2098 10.2337/dc09-0745 19875606
12. AP Kengne A Patel S Colagiuri, et al. 2010 The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study Diabetologia 53 821 831 1:STN:280:DC%2BC3c3ksVyrtw%3D%3D 10.1007/s00125-010-1681-4 20157695
13. NHG-Standaard Cardiovasculair risicomanagement. Available from http://nhg.artsennet.nl/kenniscentrum/k-richtlijnen/k-nhgstandaarden/ NHGStandaard/M84-std.htm#Risicoschatting, accessed 7 June 2010
14. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). www.nice.org.uk/nicemedia/pdf/CG66FullGuideline0509.pdf, accessed 7 June 2010
15. Guidelines & Protocols Advisory Committee. Cardiovascular disease-primary prevention. Available from www.bcguidelines.ca/gpac/pdf/cvd.pdf, accessed 7 June 2010
16. JW Beulens EM Monninkhof WM Verschuren, et al. 2009 Cohort profile: the EPIC-NL study Int J Epidemiol 10.1093/ije/dyp217 19483199
17. H Boeing A Korfmann MM Bergmann 1999 Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition Ann Nutr Metab 43 205 215 1:CAS:528:DyaK1MXotFygtbw%3D 10.1159/000012787 10592369
18. RMC Herings A Bakker BHC Stricker G Nap 1992 Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts J Epidemiol Community Health 46 136 140 1:STN:280:DyaK383mtVWgtQ%3D%3D 10.1136/jech.46.2.136 1349911
19. MM Bergmann U Bussas H Boeing 1999 Follow-up procedures in EPIC-Germany-data quality aspects. European Prospective Investigation into Cancer and Nutrition Ann Nutr Metab 43 225 234 1:CAS:528:DyaK1MXotFygtbo%3D 10.1159/000012789 10592371
20. ART Donders GJMG van der Heijden T Stijnen KGM Moons 2006 Review: a gentle introduction to imputation of missing values J Clin Epidemiol 59 1087 1091 10.1016/j.jclinepi.2006.01.014 16980149
21. Harrell FE Jr (2001) Regression modeling strategies. Springer, New York
22. S Zoungas BE de Galan T Ninomiya, et al. 2009 The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE Diabetes Care 32 2068 2074 1:CAS:528:DC%2BD1MXhsVOgtrbP 10.2337/dc09-0959 19651921
23. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A (2005) European cardiovascular disease statistics. British Heart Foundation, London, pp 57. Available from www.heartstats.org/uploads/documents%5CPDF.pdf, accessed 7 June 2010
24. AF Sandbaek SJ Griffin GF Rutten, et al. 2008 Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study Diabetologia 51 1127 1134 1:STN:280:DC%2BD1czlt12qug%3D%3D 10.1007/s00125-008-1013-0 18443762
25. DG Altman Y Vergouwe P Royston KG Moons 2009 Prognosis and prognostic research: validating a prognostic model BMJ 338 b605 10.1136/bmj.b605 19477892
26. KG Moons DG Altman Y Vergouwe P Royston 2009 Prognosis and prognostic research: application and impact of prognostic models in clinical practice BMJ 338 b606 10.1136/bmj.b606 19502216